Abstract
Liver fatty acid-binding protein (L-FABP) expression is modulated by developmental, hormonal, dietary, and pharmacological factors. The most pronounced induction is seen after treatment with peroxisome proliferators, which induce L-FABP coordinately with microsomal cytochrome P-450 4A1 and the enzymes of peroxisomal fatty acid β-oxidation. These effects of peroxisome proliferators may be mediated by a receptor which has been shown to be activated by peroxisome proliferators in mammalian cell transfection studies. However, the peroxisome proliferators tested thus far do not bind to this receptor, known as the peroxisome proliferator-activated receptor (PPAR), and its endogenous ligand(s) also remain unknown. Peroxisome proliferators inhibit mitochondrial β-oxidation, and one hypothesis is that the dicarboxylic fatty acid metabolites of accumulated LCFA, formed via the P-450 4A1 ω-oxidation pathway, serve as primary inducers of L-FABP and peroxisomal β-oxidation. We have tested this hypothesis in primary hepatocyte cultures exposed to clofibrate (CF). Inhibition of P-450 4A1 markedly diminished, via a pre-translational mechanism, the CF induction of L-FABP and peroxisomal β-oxidation. In further experiments, long-chain dicarboxylic acids, the final products of the P-450 4A1 ω-oxidation pathway, but not LCFA, induced L-FABP and peroxisomal β-oxidation pre-translationally. These results suggest a role, in part, for long-chain dicarboxylic acids in mediating the peroxisome proliferator induction of L-FABP and peroxisomal β-oxidation. We also found that LCFA, which undergo rapid hepatocellular metabolism, could become inducers of L-FABP and peroxisomal β-oxidation under conditions where their metabolism was inhibited. The role of the PPAR in mediating these effects is unknown, but clearly warrants further study. The induction of L-FABP and peroxisomal β-oxidation by LCFA and/or their ω-oxidized metabolites may provide a means for limiting the deleterious effects of increased intracellular concentrations of free LCFA, and thus act as an important hepatocellular adaptation to impairment or overload of mitochondrial LCFA oxidation.
Similar content being viewed by others
References
Bass NM: The cellular fatty acid-binding proteins: Aspects of structure, regulation, and function. Int Rev Cytol Vol III: 143–184, 1988
Kaikaus RM, Bass NM, Ockner RK: Functions of fatty acid binding proteins. Experientia 46: 617–630, 1990
Hauft SM, Sweetser DA, Rotwein PS, Lajara R, Hoppe PC, Birkenmeyer EH, Gordon JI: A transgenic mouse model that is useful for analyzing cellular and geographical diffentiation of the intestine during fetal development. J Biol Chem 264: 8419–8429, 1989
Sheridan M, Wilkinson TCI, Wilton D: Studies on fatty acid binding proteins during development in the rat. Biochem J 242: 919–922, 1987
Sweetser DA, Birkenmeyer EH, Hoppe PC, McKeel DW, Gordon JI: Mechanisms underlying generation of gradients in gene expression within the intestine. An analysis using transgenic mice containing fatty acid binding proteins-human growth hormone fusion genes. Genes Dev 2: 1318–1322, 1988
Ockner RK, Lysenko N, Manning JA, Monroe SE, Burnett DA: Sex steroid modulation of fatty acid utilization and fatty acid binding protein concentration in rat liver. J Clin Invest 65: 1013–1023, 1980
Bass NM, Barker ME, Manning JA, Jones AL, Ockner RK: Acinar heterogeneity of fatty acid binding protein expression in the livers of male, female and clofibrate-treated rats. Hepatology 9: 12–21, 1989
Kawashima Y, Uy-Yu N, Kozuka H: Sex-related difference in inductions by perfluoro-octanoic acid of peroxisomal β-oxidation, microsomal 1-acylglycerophophocholine acyltransferase and cytosolic acyl-CoA hydrolase in rat liver. Biochem J 261: 595–600, 1989
Shevchuk O, Baraona E, Xiao-Li M, Pignon J-P, Lieber C: Sex differences in the response of hepatic fatty acids and cytosolic fatty acid binding capacity to alcohol consumption in rats. Proc Soc Exp Biol Med 198: 584–590, 1991
Green RP, Birkenmeyer EH, Beamer WG, Maltais LJ, Gordon JI: The hypothyroid (hyt/hyt) mouse: a model system for studying the effects of thyroid hormone on developmental changes in gene expression. Proc Natl Acad Sci USA 85: 5592–5596, 1988
Pignon J-P, Bailey NC, Baraona E, Lieber C: Fatty acid-binding protein: A major contributor to the ethanol-induced increase in liver cytosolic proteins in the rat. Hepatology 7: 865–871, 1987
Bass NM, Manning JA, Ockner RK, Gordon JI, Seetharam S, Alpers DH: Regulation of the biosynthesis of two distinct fatty acid-binding proteins in rat liver and intestine: Influences of sex differences and of clofibrate. J Biol Chem 260: 1432–1436, 1985
Hawkins JM, Jones WE, Bonner FW, Gibson GG: The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney. Drug Metabolism Reviews 18 (4): 441–515, 1987
Lock EA, Mitchell AM, Elcombe CR: Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annu Rev Pharmacol Toxicol 29: 145–163, 1989
Hardwick JP, Byung-Joon S, Huberman E, Gonzalez FJ: Isolation, complementary DNA sequence, and regulation of rat hepatic lauric acid ω-hydroxylase (cytochrome P-450LAW). J Biol Chem 262: 801–810, 1987
Reddy JK, Goel SK, Nemali MR, Carrino JJ, Laffler TG, Reddy MK, Sperbeck SJ, Osumi T, Hashimoto T, Lalwani ND, Rao MS: Transcriptional regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. Proc Natl Acad Sci USA 83: 1747–1751, 1986
Alvares K, Carillo A, Yuan PM, Kawano H, Morimoto RI, Reddy JK: Identification of cytosolic peroxisome proliferator binding protein as a member of the heat shock protein HSP70 family. Proc Natl Acad Sci USA 87: 5293–5297, 1990
Issemann I, Green S: Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347: 645–650, 1990
Tugwood JD, Issemann I, Anderson RG, Bundell KR, McPheat WL, Green S: The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J 11: 433–439, 1992
Green S: Receptor-mediated mechanisms of peroxisome proliferators. Biochem Pharmacol 43: 393–401, 1992
Bronfman M, Orellana A, Morales MN, Bieri F, Waechter F, Staubli W, Bentley P: Potentiation of diacylglycerol-activated protein kinase C by acyl-CoA thioesters of hypolipidemic drugs. Biochem Biophys Res Commun 159: 1026–1031, 1989
Watanabe T, Okawa S, Itoga H, Imanaka T, Suga T: Involvement of calmodulin- and protein kinase C-related mechanism in an induction process of peroxisomal β-oxidation-related enzymes by hypolipidemic peroxisome proliferators. Biochim Biophys Acta 1135: 84–90, 1992
Hsieh J-C, Jurutka PW, Galligan MA, Terpening CM, Haussler CA, Samuels DC et al.: Human vitamin D3 receptor is selectively phosphorylated by protein kinase C on serine 51, residue crucial to its trans-activation function. Proc Natl Acad Sci USA 88: 9315–9319, 1992
Sharma R, Lake BG, Foster J, Gibson GG: Microsomal cytochrome P-452 induction and peroxisome proliferation by hypolipidemic agents in rat liver. Biochem Pharmacol 37: 1193–201, 1988
Bronfman M, Amigo L, Morales MN: Activation of hypolipidaemic drugs to acyl-coenzyme A thioesters. Biochem J 239: 781–784, 1986
Eacho PI, Foxworthy PS: Inhibition of hepatic fatty acid oxidation by bezafibrate and bezafibroyl-CoA. Biochem Biophys Res Commun 157: 1148–1153, 1988
Bell DR, Bars RG, Gibson GG, Elcombe CR: Localization and differential induction of cytochrome P-450IVA and acyl-CoA oxidase in rat liver. Biochem J 275: 247–252, 1991
Milton MN, Elcombe CR, Gibson GG: On the mechanism of induction of microsomal cytochrome P450IVA1 and peroxisome proliferation in rat liver by clofibrate. Biochem Pharmacol 40: 2727–2732, 1990
Brandes R, Kaikaus RM, Lysenko N, Ockner RK, Bass NM: Induction of fatty acid binding protein by peroxisome proliferators in primary hepatocyte cultures and its relationship to the inductin of peroxisomal β-oxidation. Biochim Biophys Acta 1034: 53–61, 1990
Muakkassah-Kelly S, Bieri F, Waechter F, Bentley P, Staubli W: The use of adult rat primary hepatocytes to study induction of enzymes and DNA synthesis: Effect of nafenopin and electroporation. Experientia 44: 823–827, 1988
Thangada S, Alvares K, Mangino M, Usman MI, Rao MS, Reddy JK: Anin vitro demonstration of peroxisome proliferation and increase in peroxisomal β-oxidation system mRNAs in cultured rat hepatocytes treated with ciprofibrate. FEBS Lett 250: 205–210, 1989
Bissell DM, Arenson DM, Maher JJ, Roll FJ: Support of cultured hepatocytes by a laminin-rich gel: Evidence for a functionally significant subendothelial matrix in normal rat liver. J Clin Invest 79: 801–812, 1987
Hertz R, Arnon J, Bar-Tana J: The effect of bezafibrate and long-chain fatty acids on peroxisomal activities in cultured rat hepatocytes. Biochim Biophys Acta 836: 192–200, 1985
Reich NO, Ortiz de Montellano PR: Dissociation of increased lauric acid ϖ-hydroxylase activity from the antilipidemic action of clofibrate. Biochem Pharmacol 35: 1227–1233, 1986
Ortiz de Montellano PR, Mathews JM, Langry KC: Autocatalytic inactivation of cytochrome P-450 and chloroperoxidase by 1-aminobenzotriazole and other aryne precursors. Tetrahedron 40: 511–519, 1984
CaJacob CA, Chan WK, Shephard E, Ortiz de Montellano PR: The catalytic site of rat hepatic lauric acid ϖ-hydroxylase. J Biol Chem 263: 18640–18649, 1988
Kaikaus RM, Chan WK, Lysenko N, Ortiz de Montellano PR, Bass NM: Induction of liver fatty acid binding protein (L-FABP) and peroxisomal fatty acid β-oxidation by peroxisome proliferators (PP) is dependent on cytochrome P-450 activity. Hepatology 12: 899A, 1990
Flatmark T, Nilsson A, Kvannes J, Eijhom TS, Fukami MH, Kryvi H, Christiansen EN: On the mechanism of induction of the enzyme systems for peroxisomal β-oxidation of fatty acids in rat liver by diets rich in partially hydrogenated fish oil. Biochim Biophys Acta 962: 122–130, 1990
Neat CE, Thomassen MS, Osmundsen H: Induction of peroxisomal β-oxidation in rat liver by high fat diets. Biochem J 186: 369–371, 1980
Christiansen EN, Gray TJB, Lake BG: Effects of very long-chain fatty acids on peroxisomal β-oxidation in primary rat hepatocyte cultures. Lipids 20: 929–932, 1985
Suzuki H, Yamada J, Watanabe T, Suga T: compartmentation of dicarboxylic acid β-oxidation in rat liver: importance of peroxisomes in the metabolism of dicarboxylic acids. Biochim Biophys Acta 990: 25–30, 1989
Berge RK, Aarsland A, Kryvi H, Bremer J, Aarsaether N: Alkylthiacetic acid (3-thia fatty acids)—a new group of non-β-oxidizable, peroxisome-inducing fatty acid analogues. Biochim Biophys Acta 1004: 345–356, 1989
Hertz R, Bar-Tana J, Sujatta M, Pill J, Schmidt FH, Fahimi HD: The induction of liver peroxisomal proliferation by β, β′-methylsubstituted hexadecanedioic acid (MEDICA-16). Biochem Pharmacol 37: 3571–3577, 1988
Kaikaus RM, Lysenko N, Ockner RK, Bass NM: Long-chain monocarboxylic fatty acids induce peroxisomal β-oxidation and liver fatty-acid-binding protein during inhibition of carnitine palmitoyltransferase I. Gastroenterology 102: A828, 1992
Kiorpes TC, Hoerr D, Ho W, Weaner LE, Inman MG, Tutweiler GF: Identification of 2-tetradecylglycidyl coenzyme-A as the active form of methyl 2-tetradecylglycidate (methyl palmoxirate) and its characterization as an irreversible, active site-directed inhibitor of carnitine palmitoyltransferase I in isolated rat liver mitochondria. J Biol Chem 259: 9750–9755, 1984
Heubi JE, Partin JC, Partin JS, Schubert WK: Reye's syndrome: Current concepts. Hepatology 7: 155–164, 1987
Vergani L, Fanin M, Martinuzzi A, Galassi A, Appi A, Carrozzo R, Roza M, Angelini C: Liver fatty acid binding protein in two cases of human lipid storage. Mol Cell Biochem 98: 225–230, 1990
Deschamps D, Fisch C, Fromenty B, Berson A, Degott C, Pessayre D: Inhibition by salicylic acid of the mitochondrial activation and β-oxidation of long-chain fatty acids. Possible role in the development of Reye's syndrome. Hepatology 12: 927A, 1990
Tonsgard JH, Getz GS: Effect of Reye's syndrome serum on isolated chinchilla liver mitochondria. J Clin Invest 76: 816–825, 1985
Gottlicher M, Widmark E, Li Q, Gustafsson JA: Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc Natl Acad Sci USA 89: 4653–4657, 1992
Murakami K, Routtenberg A: Direct activation of purified protein kinase C by unsaturated fatty acids (oleate and arachidonate) in the absence of phospholipids and Ca++. FEBS 192: 189–193, 1985
Bosca L, Diaz-Guerra MJM, Mojena M: Oleate-induced translocation of protein kinase C to hepatic microsomal membranes. Biochem Biophys Res Commun 160: 1243–1249, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kaikaus, R.M., Chan, W.K., de Montellano, P.R.O. et al. Mechanisms of regulation of liver fatty acid-binding protein. Mol Cell Biochem 123, 93–100 (1993). https://doi.org/10.1007/BF01076479
Issue Date:
DOI: https://doi.org/10.1007/BF01076479